RxDoctor Payments Data

Daniela Rojas-Molina, MD

Family Medicine · Ellijay, GANPI 1043203599

Payments from drug & device makers

$1,327in general payments, 2019–2025

Across 73 payments — averaging $18.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$313
  • Lilly USA, LLC$152
  • GSK$134
  • Amgen$74
  • Indivior Inc.$70
  • Takeda Pharmaceuticals U.S.A., Inc.$66
  • plus $518 from 14 others

What the payments were for

  • Food & beverage$1,327100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,327 in reported general payments places this provider in the 60th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$880
Medicare patients
38
Services billed
116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metformin Er GastricMetformin Hcl36$387,587
OzempicSemaglutide49$98,166
EliquisApixaban46$46,073
TrulicityDulaglutide22$38,039
MounjaroTirzepatide24$29,266
JanuviaSitagliptin Phosphate16$27,128
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog35$22,592
Spiriva HandihalerTiotropium Bromide11$16,017
ShingrixVaricella-Zoster Ge/As01b/Pf67$14,887
FarxigaDapagliflozin Propanediol16$13,827
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog17$13,667
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl77$12,306
TradjentaLinagliptin15$12,113
Advair HfaFluticasone Propion/Salmeterol18$11,170
Tresiba Flextouch U-100Insulin Degludec14$9,421

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$62$98,16649 claims
Lilly USA, LLCTrulicity, Mounjaro$152$67,30646 claims
PfizerEliquis$16$46,07346 claims
MerckJanuvia$44$27,12816 claims
GSKShingrix, Trelegy Ellipta$134$23,91879 claims
AstraZenecaFarxiga, Symbicort$49$16,66128 claims
Sanofi-aventis U.S. LLCLantus$25$3,16311 claims
AbbVieSynthroid$313$1,36414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Ellijay

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →